Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Halozyme Therapeutics (HALO) Q2 2024 Earnings
HALO
-1.45%
7
May
Confirmed
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0.62
0.69
0.75
0.82
Details
Expected EPS
0.68653
Actual EPS
0.79
Surprise EPS
0.1
Surprise Percent
+15.07%
Description
Halozyme Therapeutics (HALO) has reported earnings of 0.79 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login